Diversified science and technology company Danaher (NYSE: DHR) will be announcing earnings results this Tuesday morning. Here’s what to expect.
Danaher beat analysts’ revenue expectations by 1.7% last quarter, reporting revenues of $5.94 billion, up 3.4% year on year. It was a satisfactory quarter for the company, with a beat of analysts’ EPS estimates but revenue guidance for next quarter slightly missing analysts’ expectations.
Is Danaher a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Danaher’s revenue to grow 3.6% year on year to $6.01 billion, in line with the 3.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.72 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Danaher has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 0.9% on average.
With Danaher being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unravel for life sciences tools & services stocks. However, there has been positive investor sentiment in the segment, with share prices up 2.6% on average over the last month. Danaher is up 9.4% during the same time and is heading into earnings with an average analyst price target of $243.55 (compared to the current share price of $208.40).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
